CF101 for the treatment of autoimmune inflammatory diseases: data from phase 2 clinical trials in patients with rheumatoid arthritis, psoriasis and dry eye syndrome

Authors
Category Primary study
JournalPURINERGIC SIGNALLING
Year 2010
This article has no abstract
Epistemonikos ID: d2a574645541d1bcf587ca0c513ae609face87b8
First added on: Feb 15, 2022